House com­mit­tee to in­ves­ti­gate FDA's re­sponse to on­go­ing drug short­ages

Re­pub­li­can lead­ers of the House Com­mit­tee on En­er­gy & Com­merce sent a five-page let­ter yes­ter­day an­nounc­ing an in­ves­ti­ga­tion in­to the on­go­ing drug short­ages that have ran­kled the US dur­ing the pan­dem­ic and the FDA’s re­sponse to it.

The let­ter, signed by Chair Cathy Mc­Mor­ris Rodgers (R-WA), ex­plains how short­ages have be­come more com­mon over the past decade, while point­ing to a re­port from the Na­tion­al Acad­e­mies of Sci­ence, En­gi­neer­ing and Med­i­cine find­ing that drug short­ages have been “on the rise” over the past sev­er­al decades and are last­ing longer, with new drug short­ages in the US see­ing a 30% in­crease from 2021 to 2022.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN